South and Central America Cell Therapy Bioprocessing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (Bioreactor, Lyophilization, Electrospinning, Control flow Centrifugation, Ultrasonic Lysis, Genome Editing Technology, Cell Immortalization Technology, and Viral Vector Technology); Cell Type (Stem Cell, Immune Cell, Human Embryonic Stem Cell, Pluripotent Stem Cell, and Hematopoietic Stem Cells), Indication (Cardiovascular Disease (CVD), Oncology, Wound Healing, Orthopaedic, and Others); End User (Hospitals and Clinics, Diagnostic Centres, Regenerative Medicine Centres, and Academic and Research Institute)
Market Introduction
Cell therapy bioprocessing is a subfield of bioprocess engineering that bridges cell therapy and bioprocessing (i.e., biopharmaceutical manufacturing). Cell therapy is one of the fastest-growing areas of the life sciences. It entails delivering entire living cells to a patient to treat disease.
Thus, the growing approvals for cell therapies is expected to create a significant demand for cell therapy bioprocessing in the coming years, which is further anticipated to drive the cell therapy bioprocessing market.
COVID-19 cases are increasing in South and Central America. With the outbreak of the second wave of COVID-19, the number of cases in SCAM countries has increased. Despite this impact, the region's biotechnology industry is doing little to fight the virus, and the lack of projects has exposed the sector's vulnerability. There are a few unrelated and autonomous projects going on, but they are happening independently of one another, meaning that there is no strong biotech network. Currently, Brazil has the second highest reported cases of COVID-19 infection across the world. Brazilian Association of Hematology, Hemotherapy and Cellular Therapy have constituted a panel of experts to carefully examine and review the use of cellular therapies for the treatment of COVID 19. Such an initiatives will bring significant growth for cell therapy bioprocessing market in long run.
Get more information on this report :
Market Overview and Dynamics
The Cell therapy bioprocessing market in South and Central America is expected to grow from US$ 458.2 million in 2021 to US$ 994.7 million by 2028; it is estimated to grow at a CAGR of 11.7% from 2021 to 2028. Automated procedures will also help in scaling-up the production volumes and continuous production of different batches with minimal tracking. It will also increase productivity by enabling the rapid expansion of manufacturing capability. There have been several instances of companies developing automated processes. In July 2020, Thermo Fisher Scientific Inc., and Lyell Immunopharma entered a partnership to develop and manufacture processes to design effective cell therapies for cancer patients. Under this partnership, the companies aim to improve fitness of T-cells and support the development of an integrated cGMP compliant platform (system and software) along with reagents, consumables, and instruments. Likewise, in March 2019, Lonza entered a partnership with Israel’s Sheba Medical Center to provide automated and closed CAR-T manufacturing using its point-of-care Cocoon cell therapy manufacturing platform. Thus, the adoption of automated procedures will help overcome the challenges associated with cell therapy bioprocessing and offer growth opportunities to the market players that will contribute to the market growth in the coming years.
Key Market Segments
In terms of technology, the bioreactors segment accounted for the largest share of the South and Central America cell therapy bioprocessing market in 2020. In terms of cell type, the stem cell segment accounted for the largest share of the South and Central America cell therapy bioprocessing market in 2020. In terms of indication, the oncology segment accounted for the largest share of the South and Central America cell therapy bioprocessing market in 2020. In terms of end user, the academic and research institute segment held a larger market share of the cell therapy bioprocessing market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the Cell therapy bioprocessing market in South and Central America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Fresenius Kabi Ag., Asahi Kasei Corporation, Sartorius Ag, Merck Kgaa, Thermo Fisher Scientific Inc., Corning Incorporated, Cytiva (Ge Healthcare), Lonza, Repligen, and Catalent Inc.
Reasons to buy report
- To understand the South and Central America Cell therapy bioprocessing market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for South and Central America Cell therapy bioprocessing market
- Efficiently plan M&A and partnership deals in South and Central America Cell therapy bioprocessing market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form South and Central America Cell therapy bioprocessing market
- Obtain market revenue forecast for market by various segments from 2021-2028 in South and Central America region.
SOUTH AND CENTRAL AMERICA CELL THERAPY BIOPROCESSING MARKET SEGMENTATION
By Technology
- Bioreactor
- Lyophilization
- Electrospinning
- Control flow Centrifugation
- Ultrasonic Lysis
- Genome Editing Technology
- Cell Immortalization Technology
- Viral Vector Technology
By Cell Type
- Stem Cell
- Immune Cell
- Human Embryonic Stem Cell
- Pluripotent Stem Cell
- Hematopoetic Stem Cell
By Indication
- Cardiovascular Disease (CVD)
- Oncology
- Wound Healing
- Orthopedic
- Others
By End User
- Hospitals and Clinics
- Diagnostic Centers
- Regenerative Medicine Centers
- Academic and Research Institute
By Country
- South and Central America
- Brazil
- Argentina
- Rest of South and Central America
Companies Mentioned
- Fresenius Kabi Ag.
- Asahi Kasei Corporation
- Sartorius Ag
- Merck Kgaa
- Thermo Fisher Scientific Inc.
- Corning Incorporated
- Cytiva (Ge Healthcare)
- Lonza
- Repligen
- Catalent Inc
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Cell Therapy Bioprocessing Market – By Technology
1.3.2 Cell Therapy Bioprocessing Market – By Cell Type
1.3.3 Cell Therapy Bioprocessing Market – By Indication
1.3.4 Cell Therapy Bioprocessing Market – By End User
1.3.5 South and Central America Cell Therapy Bioprocessing Market – By Country
2. South and Central America Cell Therapy Bioprocessing Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South and Central America Cell Therapy Bioprocessing Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Cell Therapy Bioprocessing Market- South and Central America PEST Analysis
4.3 Expert Opinion
5. South and Central America Cell Therapy Bioprocessing Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Investments for Cell and Gene Therapy Manufacturing
5.1.2 Growing Approvals for Cell Therapies
5.2 Market Restraints
5.2.1 Challenges Associated with Cell Therapy Bioprocessing
5.3 Market Opportunities
5.3.1 Automated Procedures to Produce Cell Therapies
5.4 Future Trends
5.4.1 Digital Biomanufacturing
5.5 Impact Analysis
6. Cell Therapy Bioprocessing Market – South and Central America Analysis
6.1 South and Central America Cell Therapy Bioprocessing Market Revenue Forecasts and Analysis
7. South and Central America Cell Therapy Bioprocessing Market Analysis and Forecasts To 2028 – By Technology
7.1 Overview
7.2 Cell Therapy Bioprocessing Market Revenue Share, by Technology (2020 and 2028)
7.3 Bioreactor
7.3.1 Overview
7.3.2 Bioreactor: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
7.4 Lyophilization
7.4.1 Overview
7.4.2 Lyophilization: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
7.5 Electrospinning
7.5.1 Overview
7.5.2 Electrospinning: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
7.6 Control flow Centrifugation
7.6.1 Overview
7.6.2 Control flow Centrifugation: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
7.7 Ultrasonic Lysis
7.7.1 Overview
7.7.2 Ultrasonic Lysis: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
7.8 Genome Editing Technology
7.8.1 Overview
7.8.2 Genome Editing Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
7.9 Cell Immortalization Technology
7.9.1 Overview
7.9.2 Cell Immortalization Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
7.10 Viral Vector Technology
7.10.1 Overview
7.10.2 Viral Vector Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
8. Cell Therapy Bioprocessing Market Analysis – By Cell Type
8.1 Overview
8.2 Cell Therapy Bioprocessing Market Revenue Share, by Cell Type (2020 and 2028)
8.3 Stem Cell
8.3.1 Overview
8.3.2 Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
8.4 Immune Cell
8.4.1 Overview
8.4.2 Immune Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
8.5 Human Embryonic Stem Cell
8.5.1 Overview
8.5.2 Human Embryonic Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
8.6 Pluripotent Stem Cell
8.6.1 Overview
8.6.2 Pluripotent Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
8.7 Hematopoietic Stem Cell
8.7.1 Overview
8.7.2 Hematopoietic Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
9. South and Central America Cell Therapy Bioprocessing Market Analysis and Forecasts To 2028 – By Indication
9.1 Overview
9.2 Cell Therapy Bioprocessing Market Revenue Share, by Indication (2020 and 2028)
9.3 Cardiovascular Disease (CVD)
9.3.1 Overview
9.3.2 Cardiovascular Disease (CVD): Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
9.4 Oncology
9.4.1 Overview
9.4.2 Oncology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
9.5 Wound Healing
9.5.1 Overview
9.5.2 Wound Healing: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
9.6 Orthopaedic
9.6.1 Overview
9.6.2 Orthopaedic: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
10. South and Central America Cell Therapy Bioprocessing Market Analysis and Forecasts to 2028– By End User
10.1 Overview
10.2 Cell Therapy Bioprocessing Market Revenue Share, by End User (2020 and 2028)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals and Clinics: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
10.4 Diagnostic Centres
10.4.1 Overview
10.4.2 Diagnostic Centres: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
10.5 Regenerative Medicine Centres
10.5.1 Overview
10.5.2 Regenerative Medicine Centres: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
10.6 Academic and Research Institute
10.6.1 Overview
10.6.2 Academic and Research Institute: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
11. Cell Therapy Bioprocessing Market Revenue and Forecasts to 2028 – Geographical Analysis
11.1 South and Central America: Cell Therapy Bioprocessing Market Revenue and Forecast to 2028
11.1.1 Overview
11.1.2 South and Central America: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)
11.1.3 Brazil: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)
11.1.3.1 Brazil: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)
11.1.3.2 Brazil: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)
11.1.3.3 Brazil: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)
11.1.3.4 Brazil: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)
11.1.3.5 Brazil: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)
11.1.4 Argentina: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)
11.1.4.1 Argentina: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)
11.1.4.2 Argentina: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)
11.1.4.3 Argentina: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)
11.1.4.4 Argentina: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)
11.1.4.5 Argentina: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)
11.1.5 Rest of SCAM: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)
11.1.5.1 Rest of SCAM: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)
11.1.5.2 Rest of SCAM: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)
11.1.5.3 Rest of SCAM: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)
11.1.5.4 Rest of SCAM: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)
11.1.5.5 Rest of SCAM: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)
12. Impact Of COVID-19 Pandemic on South and Central America Cell Therapy Bioprocessing Market
12.1 South and Central America: Impact Assessment of COVID-19 Pandemic
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. COMPANY PROFILES
14.1 Fresenius Kabi AG
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Asahi Kasei Corporation
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Sartorius AG
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 MERCK KGaA
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 THERMO FISHER SCIENTIFIC INC.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Corning Incorporated
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Cytiva
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Lonza
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Repligen
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Catalent Inc
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About the Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. Brazil: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 2. Brazil: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)
Table 3. Brazil: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 4. Brazil: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 5. Argentina: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 6. Argentina: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)
Table 7. Argentina: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 8. Argentina: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 9. Rest of SCAM: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 10. Rest of SCAM: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)
Table 11. Rest of SCAM: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 12. Rest of SCAM: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 13. Organic Developments Done By Companies
Table 14. Inorganic Developments Done By Companies
Table 15. Glossary of Terms, Cell Therapy Bioprocessing Market
LIST OF FIGURES
Figure 1. Cell Therapy Bioprocessing Market Segmentation
Figure 2. South and Central America Cell Therapy Bioprocessing Market Overview
Figure 3. Bioreactor Segment Held Largest Share of Technology in Cell Therapy Bioprocessing Market
Figure 4. Brazil is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Cell Therapy Bioprocessing Market - South and Central America PEST Analysis
Figure 6. Cell Therapy Bioprocessing Market Impact Analysis of Driver and Restraints
Figure 7. South and Central America Cell Therapy Bioprocessing Market – Revenue Forecasts and Analysis – 2020- 2028
Figure 8. Cell Therapy Bioprocessing Market Revenue Share, by Technology (2020 and 2028)
Figure 9. Bioreactor: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 10. Lyophilization: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 11. Electrodspinning: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 12. Control flow Centrifugation: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 13. Ultrasonic Lysis: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 14. Genome Editing Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 15. Cell Immortalization Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 16. Viral Vector Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 17. Cell Therapy Bioprocessing Market Revenue Share, by Cell Type (2020 and 2028)
Figure 18. Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 19. Immune Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 20. Human Embryonic Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 21. Pluripotent Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 22. Hematopoietic Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 23. Cell Therapy Bioprocessing Market Revenue Share, by Indication (2020 and 2028)
Figure 24. Cardiovascular Disease (CVD): Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 25. Oncology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 26. Wound Healing: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 27. Orthopaedic: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 28. Others: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 29. Cell Therapy Bioprocessing Market Revenue Share, by End User (2020 and 2028)
Figure 30. Hospitals and Clinics: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 31. Diagnostic Centres: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 32. Regenerative Medicine Centres: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 33. Academic and Research Institute: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 34. South and Central America: Cell Therapy Bioprocessing Market, by Key Country – Revenue (2020) (USD Million)
Figure 35. South and Central America: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)
Figure 36. Brazil: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. Argentina: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)
Figure 38. Rest of SCAM: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)
Figure 39. Impact of COVID-19 Pandemic in South and Central America Country Markets
Figure 40. Growth Strategies Done by the Companies in the Market, (%)
- Fresenius Kabi Ag.
- Asahi Kasei Corporation
- Sartorius Ag
- Merck Kgaa
- Thermo Fisher Scientific Inc.
- Corning Incorporated
- Cytiva (Ge Healthcare)
- Lonza
- Repligen
- Catalent Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South and Central America cell therapy bioprocessing market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the South and Central America cell therapy bioprocessing market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth South and Central America market trends and outlook coupled with the factors driving the cell therapy bioprocessing market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution